All Brands Owned by Pfizer
Pfizer owns 5 brands in our database. Browse the complete portfolio of Pfizer subsidiaries and brands across various industries.
Company Type
public
Headquarters
New York, New York, USA
Brand Portfolio
5 brands
Stock
NYSE: PFE
Filter by Category
Complete Brand Portfolio
Celebrex
Owned by Pfizer
Prescription anti-inflammatory medication for treating arthritis pain and inflammation, manufactured and marketed by Pfizer.
Diflucan
Owned by Pfizer
Prescription antifungal medication for treating fungal infections including candidiasis and cryptococcal meningitis, manufactured and marketed by Pfizer.
Eliquis
Owned by Pfizer
Prescription anticoagulant medication for preventing blood clots and stroke in patients with atrial fibrillation, manufactured and marketed by Pfizer.
Leucovorin
Owned by Pfizer
Generic prescription folinic acid (5-formyltetrahydrofolate) used for methotrexate rescue in high-dose methotrexate chemotherapy, as a biochemical modulator of fluorouracil (5-FU) in colorectal cancer regimens including FOLFOX and FOLFIRI, and for treatment of megaloblastic anemia; originally developed by Lederle Laboratories in the 1940s and now manufactured by multiple pharmaceutical companies including Pfizer/Hospira, Teva, and Fresenius Kabi.
Norvasc
Owned by Pfizer
Prescription calcium channel blocker medication for treating high blood pressure and angina, manufactured and marketed by Pfizer.
About Pfizer
What does Pfizer own?
Pfizer owns a portfolio of prescription medicines and vaccines spanning oncology, cardiovascular, immunology, vaccines, and rare diseases. Key products include Eliquis (blood thinner), Prevnar (pneumococcal vaccine), Ibrance (breast cancer), Vyndaqel (rare heart disease), Paxlovid (COVID-19 antiviral), and Comirnaty (COVID-19 vaccine, with BioNTech). The 2023 acquisition of Seagen added oncology antibody-drug conjugates including Padcev, Adcetris, and Tukysa.
Is Pfizer publicly traded?
Yes, Pfizer Inc. is listed on the New York Stock Exchange under ticker PFE. The company has been publicly traded since 1944. Pfizer has no single controlling shareholder, with major institutional holders including Vanguard Group, BlackRock, and State Street. Pfizer is a component of the Dow Jones Industrial Average and the S&P 500.
Who founded Pfizer?
Pfizer was founded in 1849 in Brooklyn, New York by Charles Pfizer and his cousin Charles Erhart. Charles Pfizer was a German-born chemist who emigrated to the United States. The company's first product was santonin, an antiparasitic agent. Pfizer's breakthrough into modern pharmaceuticals came during World War II when the company developed large-scale penicillin production.
Where is Pfizer headquartered?
Pfizer is headquartered in New York City, New York, USA. The company maintains its principal executive offices in Midtown Manhattan. Pfizer operates manufacturing facilities in the United States, Belgium, Ireland, the United Kingdom, Germany, Japan, China, India, and Brazil, and sells products in more than 125 countries worldwide.
How many products does Pfizer sell?
Pfizer sells dozens of prescription medicines and vaccines across multiple therapeutic areas. The company's portfolio includes products in oncology, vaccines, cardiovascular, immunology, rare diseases, and hospital products. More than a dozen of Pfizer's products each generate over $1 billion in annual revenue. The company's research pipeline includes hundreds of compounds in various stages of clinical development.
Who owns Pfizer?
Pfizer Inc. is publicly traded on the NYSE with a broad institutional and retail shareholder base. No single shareholder holds a controlling stake. Major institutional shareholders include Vanguard Group, BlackRock, and State Street. Albert Bourla serves as Chairman and CEO. Pfizer has no founding family or private equity controlling shareholder.
Stock Information
Competitors to Pfizer
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Novartis | Switzerland | 2015 | Mass Market | Global | All Genders | |
| Kenvue | USA | 1974 | Mass Market | North America | All Genders |
Learn More About Competitors
Cosentyx
Owned by Novartis
Prescription biologic medication for treating autoimmune diseases including psoriasis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, and other inflammatory conditions.
Motrin
Owned by Kenvue
American brand of ibuprofen pain relief medication owned by Kenvue, the consumer health spinoff from Johnson & Johnson, which is being acquired by Kimberly-Clark in a $40 billion deal announced in November 2025.
Competitive Analysis
Market Positioning: Pfizer competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Pfizer Brand Portfolio Overview
Pfizer maintains a diverse portfolio of 5 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 5 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Pfizerprovides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at Pfizer
Latest News About Pfizer
Articles About Pfizer
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Brand Spin-offs: When Companies Sell Off Their Own Brands
From Kenvue to Kellanova, major corporations are spinning off iconic brands into independent companies. Learn why, how it works, and what it means for consumers.
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.